Total Payments
$1,135
2019 Payments
$369.05
Companies
8
Transactions
60
Medicare Patients
503
Medicare Billing
$36,152
Payment Breakdown by Category
Food & Beverage$1,135 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,135 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $488.12 | 10 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $319.14 | 11 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $116.99 | 25 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $85.02 | 5 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $64.92 | 3 | $0 (2019) |
| Lundbeck LLC | $25.46 | 2 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $18.47 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.12 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $369.05 | 12 | Neurocrine Biosciences, Inc. ($154.94) |
| 2018 | $377.57 | 25 | Neurocrine Biosciences, Inc. ($152.96) |
| 2017 | $388.62 | 23 | Otsuka America Pharmaceutical, Inc. ($222.98) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Neuroscience | ||||||
| 07/13/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Schizophrenia | ||||||
| 07/02/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: NEUROLOGY | ||||||
| 06/06/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: NEUROLOGY | ||||||
| 04/25/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: NEUROLOGY | ||||||
| 04/17/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: NEUROLOGY | ||||||
| 03/22/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Schizophrenia | ||||||
| 03/07/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $118.99 | General |
| Category: PSYCHIATRY | ||||||
| 02/15/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.13 | General |
| Category: PSYCHIATRY | ||||||
| 01/10/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $113.89 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/13/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: CNS | ||||||
| 10/19/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: PSYCHIATRY | ||||||
| 09/07/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Schizophrenia | ||||||
| 08/28/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: NEUROLOGY | ||||||
| 08/14/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: CNS | ||||||
| 07/31/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROLOGY | ||||||
| 07/17/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: CNS | ||||||
| 06/26/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $1.01 | General |
| Category: CNS | ||||||
| 06/14/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: CNS | ||||||
| 06/08/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 95 | 224 | $26,145 | $8,233 |
| 2022 | 2 | 91 | 196 | $21,375 | $5,796 |
| 2021 | 4 | 159 | 319 | $35,178 | $13,171 |
| 2020 | 3 | 158 | 314 | $32,982 | $8,952 |
Total Patients
503
Total Services
1,053
Medicare Billing
$36,152
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 142 | $17,750 | $6,175 | 34.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 60 | $6,000 | $1,192 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 22 | $2,395 | $866.94 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 71 | $8,875 | $3,232 | 36.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 51 | 125 | $12,500 | $2,564 | 20.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 84 | $10,500 | $4,260 | 40.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 45 | 105 | $11,130 | $3,966 | 35.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 40 | 80 | $8,000 | $1,980 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 12 | 28 | $3,367 | $1,911 | 56.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 22 | $2,181 | $1,054 | 48.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 54 | 139 | $14,734 | $5,538 | 37.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 62 | $7,048 | $1,686 | 23.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 50 | 82 | $8,200 | $1,000 | 12.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 16 | 31 | $3,000 | $727.47 | 24.2% |
About Prakash Reddy, M.D.,
Prakash Reddy, M.D., is a Psychiatry healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376595223.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Prakash Reddy, M.D., has received a total of $1,135 in payments from pharmaceutical and medical device companies, with $369.05 received in 2019. These payments were reported across 60 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,135).
As a Medicare-enrolled provider, Reddy has provided services to 503 Medicare beneficiaries, totaling 1,053 services with total Medicare billing of $36,152. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Rochester, NY
- Active Since 05/17/2006
- Last Updated 06/30/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1376595223
Products in Payments
- REXULTI (Drug) $374.62
- INGREZZA (Drug) $319.14
- ABILIFY MAINTENA (Drug) $124.63
- LATUDA (Drug) $116.99
- INVEGA SUSTENNA (Drug) $85.02
- Fanapt (Drug) $64.92
- Trintellix (Drug) $35.59
- TRINTELLIX (Drug) $14.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Rochester
Mr. Tulio Ortega, Md, MD
Psychiatry — Payments: $246,543
Psychiatry $246,543
M Ismail, M.d, M.D
Psychiatry — Payments: $50,839
Psychiatry $50,839
Syed Mustafa, Md, MD
Psychiatry — Payments: $26,048
Psychiatry $26,048
Peter Jensen, Md, Abpn, MD, ABPN
Psychiatry — Payments: $19,612
Psychiatry $19,612
Daniel Montville, Md, MD
Psychiatry — Payments: $15,131
Psychiatry $15,131
Mark Frye, Md, MD
Psychiatry — Payments: $12,930
Psychiatry $12,930